MiR-200c and HuR in ovarian cancer.

Abstract:

BACKGROUND:MicroRNAs in solid malignancies can behave as predictors of either good or poor outcome. This is the case with members of the miR-200 family, which are the primary regulators of the epithelial to mesenchymal transition and have been reported to act as both oncogenes and tumor suppressors. This study assessed the role of miR-200c as regulator of class III β-tubulin (TUBB3), a factor associated with drug-resistance and poor prognosis in ovarian cancer. METHODS:Expression of miR-200c was assessed in a panel of ovarian cancer cell lines with inherent or acquired drug-resistance. Stable overexpression of miR-200c was obtained in A2780 and Hey cell lines. Crosslinking-coupled affinity purification method and ribonucleic-immunoprecipitation assay were used to characterise the complexes between miR-200c, HuR and 3'UTR region of TUBB3 mRNA. Nanofluidic technology and immunohistochemistry were used to analyze the expression of HuR, TUBB3 and miR-200c in 220 ovarian cancer patients. RESULTS:In a panel of ovarian adenocarcinoma cell lines, we observed a direct correlation between miR-200c expression and chemoresistance. In A2780 cells miR-200c targeted TUBB3 3'UTR, while a positive correlation was observed between miR-200c and TUBB3 expression in most of the other cell lines. Through the analysis of 3'UTR-associated complexes, we found that the miR-200c can increase the association of the RNA binding protein HuR with TUBB3 mRNA, whereas HuR binding enhanced TUBB3 mRNA translation. Most importantly, in our analysis on 220 ovarian cancer patients we observed that overexpression of miR-200c correlated with poor or good outcome depending on the cellular localization of HuR. CONCLUSION:This study suggests a model for the combined regulatory activity of miR-200c and HuR on TUBB3 expression in ovarian cancer. When HuR is nuclear, high expression of miR-200c inhibits TUBB3 expression and results in a good prognosis, whereas when HuR occurs in cytoplasm, the same miRNA enhances TUBB3 expression and produces a poor outcome. These findings reveal the usefulness of multidimensional analysis in the investigation of the prognostic role of miRNA expression.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Prislei S,Martinelli E,Mariani M,Raspaglio G,Sieber S,Ferrandina G,Shahabi S,Scambia G,Ferlini C

doi

10.1186/1471-2407-13-72

subject

Has Abstract

pub_date

2013-02-08 00:00:00

pages

72

issn

1471-2407

pii

1471-2407-13-72

journal_volume

13

pub_type

杂志文章
  • Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.

    abstract:BACKGROUND:Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is invol...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3417-z

    authors: Yang J,Zhou Y,Ng SK,Huang KC,Ni X,Choi PW,Hasselblatt K,Muto MG,Welch WR,Berkowitz RS,Ng SW

    更新日期:2017-06-17 00:00:00

  • Achieving optimal response at 12 months is associated with a better health-related quality of life in patients with chronic myeloid leukemia: a prospective, longitudinal, single center study.

    abstract:BACKGROUND:To assess the relationship between responses within 1 year and health-related quality of life (HRQoL) outcomes by exploring profiles of patients with CML-CP who were treated with front-line imatinib or nilotinib. METHODS:A prospective, longitudinal, single-center study was conducted to assess the response t...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-018-4699-5

    authors: Yu L,Wang H,Milijkovic D,Huang X,Jiang Q

    更新日期:2018-08-03 00:00:00

  • Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.

    abstract:BACKGROUND:Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening platforms, in order to persona...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3525-9

    authors: Oh DY,Jung K,Song JY,Kim S,Shin S,Kwon YJ,Oh E,Park WY,Song SY,Choi YL

    更新日期:2017-08-10 00:00:00

  • Bioinformatic analysis reveals hub genes and pathways that promote melanoma metastasis.

    abstract:BACKGROUND:Melanoma has the highest mortality rate of all skin tumors, and metastases are the major cause of death from it. The molecular mechanism leading to melanoma metastasis is currently unclear. METHODS:With the goal of revealing the underlying mechanism, three data sets with accession numbers GSE8401, GSE46517 ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07372-5

    authors: Su W,Guan Y,Huang B,Wang J,Wei Y,Zhao Y,Jiao Q,Ji J,Yu D,Xu L

    更新日期:2020-09-07 00:00:00

  • Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation.

    abstract:BACKGROUND:Ovarian tissue cryopreservation has a wide range of cancerous indications. Avoiding relapse becomes a specific concern that clinicians frequently encounter. The data about the comparative viability of cancer cells after cryopreservation are limited. This study aimed to evaluate the effect of cryopreservation...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07227-z

    authors: Du X,Todorov P,Isachenko E,Rahimi G,Mallmann P,Meng Y,Isachenko V

    更新日期:2020-08-12 00:00:00

  • The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.

    abstract:BACKGROUND:The prognostic value of rectal invasion is still unclear in stage IVA cervical cancer. The objective of this study is to evaluate patient outcome and prognostic factors in stage IVA cervical cancer treated with radiation therapy. METHODS:A retrospective review of the medical records of patients treated with...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2268-3

    authors: Wakatsuki M,Kato S,Kiyohara H,Ohno T,Karasawa K,Tamaki T,Ando K,Shiba S,Kamada T,Nakano T

    更新日期:2016-03-23 00:00:00

  • Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

    abstract:BACKGROUND:Germline mutations in the DNA mismatch repair genes predispose to Lynch syndrome, thus conferring a high relative risk of colorectal and endometrial cancer. The MLH1, MSH2 and MSH6 mutational spectrum reported so far involves minor alterations scattered throughout their coding regions as well as large genomi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-544

    authors: Thodi G,Fostira F,Sandaltzopoulos R,Nasioulas G,Grivas A,Boukovinas I,Mylonaki M,Panopoulos C,Magic MB,Fountzilas G,Yannoukakos D

    更新日期:2010-10-11 00:00:00

  • Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.

    abstract:BACKGROUND:CRC is one of the most common malignancies worldwide, and its molecular mechanisms remain unclear. Elevated levels of BAG3 have been reported in various tumors. The present study aimed to explore the expression and function of BAG3 in CRC. METHODS:BAG3 protein expression was evaluated in 90 CRC specimens us...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4657-2

    authors: Li N,Chen M,Cao Y,Li H,Zhao J,Zhai Z,Ren F,Li K

    更新日期:2018-08-06 00:00:00

  • Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

    abstract:BACKGROUND:Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce type I interferons and other cytokines, which drive an inflammatory response and activate the adaptiv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-665

    authors: González-Reyes S,Marín L,González L,González LO,del Casar JM,Lamelas ML,González-Quintana JM,Vizoso FJ

    更新日期:2010-12-03 00:00:00

  • Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.

    abstract:BACKGROUND:The development of metastases is a negative prognostic parameter for the clinical outcome of breast cancer. Bone constitutes the first site of distant metastases for many affected women. The purpose of this retrospective multicentre study was to evaluate if and how different variables such as primary tumour ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-016-2345-7

    authors: Diessner J,Wischnewsky M,Stüber T,Stein R,Krockenberger M,Häusler S,Janni W,Kreienberg R,Blettner M,Schwentner L,Wöckel A,Bartmann C

    更新日期:2016-05-12 00:00:00

  • Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.

    abstract:BACKGROUND:BRCA1 and BRCA2 mutations are found in a proportion of families with multiple early-onset breast cancers. There are a large number of different deleterious mutations in both genes, none of which would be detectable using standard genetic association studies. Single common variants and haplotypes of common va...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-466

    authors: Turkovic L,Gurrin LC,Bahlo M,Dite GS,Southey MC,Hopper JL

    更新日期:2010-09-01 00:00:00

  • Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.

    abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a type of head-neck cancer with a distinguishable geographic and racial distribution worldwide. Increasing evidence supports that the accumulation of additional genetic and epigenetic abnormalities is important in driving the NPC tumorigenic process. In this study, we aim to...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2714-2

    authors: Huang PY,Zeng TT,Ban X,Li MQ,Zhang BZ,Zhu YH,Hua WF,Mai HQ,Zhang L,Guan XY,Li Y

    更新日期:2016-08-22 00:00:00

  • Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

    abstract:BACKGROUND:Mammalian target of rapamycin (mTOR) inhibitors have anti-tumor effects against renal cell carcinoma, pancreatic neuroendocrine cancer and breast cancer. In this study, we analyzed the antitumor effects of mTOR inhibitors in small cell lung cancer (SCLC) cells and sought to clarify the mechanism of resistanc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1202-4

    authors: Matsumoto M,Seike M,Noro R,Soeno C,Sugano T,Takeuchi S,Miyanaga A,Kitamura K,Kubota K,Gemma A

    更新日期:2015-04-09 00:00:00

  • A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.

    abstract:BACKGROUND:The role of chemotherapy in high-risk soft tissue sarcoma is controversial. Though many patients undergo initial curative resection, distant metastasis is a frequent event, resulting in 5-year overall survival rates of only 50-60%. Neo-adjuvant and adjuvant chemotherapy (CTX) has been applied to achieve pre-...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-510

    authors: Schmitt T,Lehner B,Kasper B,Bischof M,Roeder F,Dietrich S,Dimitrakopoulou-Strauss A,Strauss LG,Mechtersheimer G,Wuchter P,Ho AD,Egerer G

    更新日期:2011-12-07 00:00:00

  • Use of NQO1 status as a selective biomarker for oesophageal squamous cell carcinomas with greater sensitivity to 17-AAG.

    abstract:BACKGROUND:Oesophageal squamous cell carcinoma (OSCC) is a major health burden in Sub-Saharan Africa, and novel chemotherapies are urgently required to combat this disease. The heat shock protein 90 (HSP90) inhibitor 17-N-allylamino-17-demethoxygeldanamycin (17-AAG) has previously been proposed as a possible candidate ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-334

    authors: Hadley KE,Hendricks DT

    更新日期:2014-05-15 00:00:00

  • Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.

    abstract:BACKGROUND:Improved insight into the molecular characteristics of the different ovarian cancer subgroups is needed for developing a more individualized and optimized treatment regimen. The aim of this study was to a) identify differentially expressed miRNAs in high-grade serous ovarian carcinoma (HGSC), clear cell ovar...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-80

    authors: Vilming Elgaaen B,Olstad OK,Haug KB,Brusletto B,Sandvik L,Staff AC,Gautvik KM,Davidson B

    更新日期:2014-02-11 00:00:00

  • Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

    abstract:BACKGROUND:Clinical trials where cancer patients were treated with protease inhibitors have suggested that the serine protease, prostasin, may act as a tumour suppressor. Prostasin is proteolytically activated by the serine protease, matriptase, which has a very high oncogenic potential. Prostasin is inhibited by prote...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-201

    authors: Selzer-Plon J,Bornholdt J,Friis S,Bisgaard HC,Lothe IM,Tveit KM,Kure EH,Vogel U,Vogel LK

    更新日期:2009-06-25 00:00:00

  • ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways.

    abstract:BACKGROUND:Amplification of the 8p11-12 region has been found in approximately 15% of human breast cancer and is associated with poor prognosis. Previous genomic analysis has led us to identify the endoplasmic reticulum (ER) lipid raft-associated 2 (ERLIN2) gene as one of the candidate oncogenes within the 8p11-12 ampl...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-225

    authors: Wang G,Liu G,Wang X,Sethi S,Ali-Fehmi R,Abrams J,Zheng Z,Zhang K,Ethier S,Yang ZQ

    更新日期:2012-06-08 00:00:00

  • EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.

    abstract:BACKGROUND:The EGFR and downstream signaling pathways play an important role in tumorigenesis in oral squamous cell carcinoma (OSCC). Gene copy number alteration is one mechanism for overexpressing the EGFR protein and was also demonstrated to be related to lymph node metastasis, tumor invasiveness and perineural invas...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3586-9

    authors: Huang SF,Chien HT,Cheng SD,Chuang WY,Liao CT,Wang HM

    更新日期:2017-08-30 00:00:00

  • Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.

    abstract:BACKGROUND:In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer death. Epidemiological studies have reported conflicting associations between statins and CRC risk and there is one published report of the association between statins and CRC survival. METHODS:Analysis was car...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-487

    authors: Lakha F,Theodoratou E,Farrington SM,Tenesa A,Cetnarskyj R,Din FV,Porteous ME,Dunlop MG,Campbell H

    更新日期:2012-10-22 00:00:00

  • CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resecta

    abstract:BACKGROUND:Although radical surgery remains the cornerstone of cure in resectable gastric cancer, survival remains poor. Current evidence-based (neo)adjuvant strategies have shown to improve outcome, including perioperative chemotherapy, postoperative chemoradiotherapy and postoperative chemotherapy. However, these reg...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-018-4770-2

    authors: Slagter AE,Jansen EPM,van Laarhoven HWM,van Sandick JW,van Grieken NCT,Sikorska K,Cats A,Muller-Timmermans P,Hulshof MCCM,Boot H,Los M,Beerepoot LV,Peters FPJ,Hospers GAP,van Etten B,Hartgrink HH,van Berge Henegouwen MI,

    更新日期:2018-09-10 00:00:00

  • The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.

    abstract:BACKGROUND:The aim of the present study was to investigate the association between matrix metalloproteinase-9 (MMP-9) expression with BRAF V600E mutation and clinicopathological features, in Iranian papillary thyroid cancer (PTC) patients. METHODS:In total, 90 participants including 60 PTC patients (15 males and 45 fe...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5112-0

    authors: Zarkesh M,Zadeh-Vakili A,Akbarzadeh M,Fanaei SA,Hedayati M,Azizi F

    更新日期:2018-12-03 00:00:00

  • Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia.

    abstract:BACKGROUND:At present pathogenic mechanisms of cancer cachexia are poorly understood. Previous evidence in animal models implicates the melanocortin-4 receptor gene (MC4R) in the development of cancer cachexia. In humans, MC4R mutations that lead to an impaired receptor function are associated with obesity; in contrast...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-85

    authors: Knoll S,Zimmer S,Hinney A,Scherag A,Neubauer A,Hebebrand J

    更新日期:2008-03-31 00:00:00

  • LAD1 expression is associated with the metastatic potential of colorectal cancer cells.

    abstract:BACKGROUND:Anchoring filament protein ladinin-1 (LAD1) was related to the aggressive progression of breast, lung, laryngeal and thyroid cancers. However, the association of LAD1 with colorectal cancer remained unknown. Here, to determine the relationship of LAD1 with colorectal cancer progression, we explored the effec...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07660-0

    authors: Moon B,Yang SJ,Park SM,Lee SH,Song KS,Jeong EJ,Park M,Kim JS,Yeom YI,Kim JA

    更新日期:2020-12-02 00:00:00

  • APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology.

    abstract:BACKGROUND:The APC tumor suppressor is mutated or downregulated in many tumor types, and is prominently localized to punctate clusters at protrusion tips in migratory cells, such as in astrocytes where it has been implicated in directed cell motility. Although APC loss is considered an initiating event in colorectal ca...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-12

    authors: Odenwald MA,Prosperi JR,Goss KH

    更新日期:2013-01-09 00:00:00

  • Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

    abstract:BACKGROUND:Sarcomas are rare malignant tumors. Accurate initial histological diagnosis is essential for adequate management. We prospectively assessed the medical management of all patients diagnosed with sarcoma in a European region over a one-year period to identify the quantity of first diagnosis compared to central...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-150

    authors: Lurkin A,Ducimetière F,Vince DR,Decouvelaere AV,Cellier D,Gilly FN,Salameire D,Biron P,de Laroche G,Blay JY,Ray-Coquard I

    更新日期:2010-04-19 00:00:00

  • Correction to: Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.

    abstract:CORRECTION:After publication of the original article [1] the authors found that the figure contained an incorrect version of Fig. 3a. This does not affect the results and conclusions of the article. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-017-3767-6

    authors: Wang X,Chen J,Wang J,Yu F,Zhao S,Zhang Y,Tang H,Peng Z

    更新日期:2018-01-11 00:00:00

  • LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target.

    abstract:BACKGROUND:Novel biomarkers are required to discern between breast tumors that should be targeted for treatment from those that would never become clinically apparent and/or life threatening for patients. Moreover, therapeutics that specifically target breast cancer (BC) cells with tumor-initiating capacity to prevent ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06986-z

    authors: Hagerling C,Owyong M,Sitarama V,Wang CY,Lin C,van den Bijgaart RJE,Koopman CD,Brenot A,Nanjaraj A,Wärnberg F,Jirström K,Klein OD,Werb Z,Plaks V

    更新日期:2020-06-10 00:00:00

  • Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.

    abstract:BACKGROUND:HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS:Between April 2002 and June...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-6-225

    authors: Orlando L,Cardillo A,Ghisini R,Rocca A,Balduzzi A,Torrisi R,Peruzzotti G,Goldhirsch A,Pietri E,Colleoni M

    更新日期:2006-09-15 00:00:00

  • The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.

    abstract:BACKGROUND:To evaluate the role of blood vascular endothelial growth factor (VEGF) kinetics in patients with locally advanced esophageal squamous cell carcinoma (ESCC) receiving curative concurrent chemoradiotherapy (CCRT). METHODS:A total of 97 locally advanced ESCC patients were enrolled. All the patients had their ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4731-9

    authors: Chen YH,Lu HI,Lo CM,Wang YM,Chou SY,Hsiao CC,Huang CC,Shih LH,Chen SW,Li SH

    更新日期:2018-08-20 00:00:00